Companies / Novo Nordisk A/S
Novo Nordisk A/S
Company- Registered trials
- 1683
- Ongoing
- 183/ 11%
- Completed
- 1386
- Related drugs
- 10
- Related conditions
- 14
Clinical trial landscape
1683 registered studies reference this company or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 1 | 466 | 36 | 414 | |
| Unknown | 413 | 54 | 334 | |
| Phase 3 | 389 | 46 | 317 | |
| Phase 4 | 175 | 9 | 150 | |
| Phase 2 | 138 | 17 | 108 | |
| Not applicable | 94 | 21 | 56 | |
| Phase 2/3 | 4 | 0 | 3 | |
| Early Phase 1 | 3 | 0 | 3 | |
| Phase 1/2 | 1 | 0 | 1 | |
| All phases | 1683 | 183 | 1386 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.